HIV Treatment Compounds Overcoming Drug Resistance
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current antiretroviral therapies for HIV-1 infections are ineffective against emerging drug-resistant HIV variants, necessitating the development of new antiretroviral agents.
Innovation Solution
A compound of formula I, comprising a 6-membered heteroaryl with specific substitutions, is used to treat HIV infections by inhibiting viral proliferation, which can be administered alone or in combination with other therapeutic agents.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If highly active antiretroviral therapies (HAART) are used to treat HIV-1 infections, then viral load is reduced and disease progression is delayed, but HIV strains resistant to current therapies emerge
Solution Approach 1:
The patent applies parameter changes by modifying the chemical structure of antiretroviral compounds through systematic variations in molecular substituents and functional groups. This creates a series of analogs with different biochemical properties that can overcome resistance mechanisms while maintaining antiviral activity against HIV-1 variants resistant to current therapies
2Reliability
If new antiretroviral agents are developed to combat drug-resistant HIV variants, then effectiveness against resistant strains is improved, but complexity of drug discovery and development increases
Solution Approach 1:
The patent applies segmentation by dividing the complex drug discovery process into systematic steps: identifying core molecular structures, generating structured analogs with specific substituent variations, and evaluating activity against resistant variants. This organized approach to compound development reduces the overall complexity of discovering new antiretroviral agents
Solution Approach 2:
The patent applies universality by designing a series of compounds with a common core structure that can be systematically modified to target multiple resistant HIV variants. This multi-functional approach allows a single chemical scaffold to address various resistance mechanisms through structured variations in molecular substituents
Data Source
AI summary
The invention provides compounds of formula (I): or a salt thereof as described herein. The invention also provides pharmaceutical compositions comprising a compound of formula (I), processes for preparing compounds of formula (I), intermediates useful for preparing compounds of formula I and therapeutic methods for treating a Retroviridae viral infection including an infection caused by the HIV virus.